Mark the 6 month anniversary of the devastating earthquake in Haiti, President Barack Obama Dominican Republic President Leonel Fernandez thanked on Monday for his country’s help, Agence France-Presse reported. ‘One of the first messages I wanted to deliver was our appreciation for the role of the Dominican Republic with the support of the international community to respond to the crisis in Haiti following the hits hits, ‘Obama said. ‘The Dominican Republic role, President Fernandez ‘s role was particularly vital. It saved lives, it continues as we how as to reconstruct and we can look again ‘.

He also said that USAID in Haiti in Haiti for the foreseeable future. We will be there for the long haul, he said (Cheney.. USAID Administrator Rajiv Shah also pointed to the need to protection for politically. Said it was said it was important to provide basic housing to protect and support a population that is extremely vulnerable. Politically, writes: Shah the devastated country the devastated country on Friday that the next best step to damaged houses that still stand, the the overall reconstruction is, He said that spending one thousand U.S. Dollars by two or three by two or three would be were set up.MetXia converts the tumor in a drugs mill , so the local manufacturing of the anti-tumor cytotoxic derivative is the CPA. MetXia potentially useful in treatment of all firm tumors and metastases thereof , in particular those in which Cyclophosphamide did proven efficacy.. MetXia is Oxford BioMedica lead gene – based cancer treatment. The product has a highly developed retrovirus is which supplies a specific human cytochrome P450 gene to tumor cells. Encodes the enzyme through the P450 gene activated the customarily used Crab chemotherapy drug, cyclophosphamide to destroyed a shape cells.

The company has a staff of around 65 split between your major facilities in Oxford and its wholly owned subsidiary, BioMedica Inc, into San Diego, California. Oxford BioMedica did corporate collaboration with Wyeth, Intervet, Viragen, MOLMED and Kiadis, and did technology licensed a series of companies, including Merck & Co, Biogen Idec is and Pfizer. With this approach. and pancreas cancer.